Article Details

Akebia Therapeutics (NASDAQ:AKBA) Cut to “Sell” at ValuEngine

Retrieved on: 2019-06-19 18:28:34

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics (NASDAQ:AKBA) Cut to “Sell” at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Baupost Group</b> LLC MA bought a new stake in Akebia Therapeutics during the 4th quarter valued at approximately $135,327,000. Strs Ohio increased ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up